Advanced search
Add to list

Chlamydophila psittaci infections in turkeys : overview of economic and zoonotic importance and vaccine development

Kristel Verminnen (UGent) and Daisy Vanrompay (UGent)
(2009) DRUGS OF TODAY. 45(suppl. B). p.147-150
Author
Organization
Abstract
We provide evidence on the multifactorial infectious etiology of respiratory disease in turkeys, Although Chlamydophila psittaci is difficult to diagnose, this entity should not be neglected in veterinary diagnostic laboratories. The present results suggest a pathogenic interplay between chlamydophila, avian metapneumovirus and Ornithobacterium rhinotracheale. Additionally, we demonstrate zoonotic transmission from turkeys to humans. Psittacosis due to contact with poultry probably occurs more often than is thought and the infection con be asymptomatic or symptomatic. There is no commercial C. psittaci vaccine available and currently the best option is an experimental major outer membrane protein-based DNA vaccine.
Keywords
CHALLENGE, PROTECTION, DNA VACCINATION, CHLAMYDIA-PSITTACI, OUTER-MEMBRANE PROTEIN

Citation

Please use this url to cite or link to this publication:

MLA
Verminnen, Kristel, and Daisy Vanrompay. “Chlamydophila Psittaci Infections in Turkeys : Overview of Economic and Zoonotic Importance and Vaccine Development.” DRUGS OF TODAY, vol. 45, no. suppl. B, 2009, pp. 147–50.
APA
Verminnen, K., & Vanrompay, D. (2009). Chlamydophila psittaci infections in turkeys : overview of economic and zoonotic importance and vaccine development. DRUGS OF TODAY, 45(suppl. B), 147–150.
Chicago author-date
Verminnen, Kristel, and Daisy Vanrompay. 2009. “Chlamydophila Psittaci Infections in Turkeys : Overview of Economic and Zoonotic Importance and Vaccine Development.” DRUGS OF TODAY 45 (suppl. B): 147–50.
Chicago author-date (all authors)
Verminnen, Kristel, and Daisy Vanrompay. 2009. “Chlamydophila Psittaci Infections in Turkeys : Overview of Economic and Zoonotic Importance and Vaccine Development.” DRUGS OF TODAY 45 (suppl. B): 147–150.
Vancouver
1.
Verminnen K, Vanrompay D. Chlamydophila psittaci infections in turkeys : overview of economic and zoonotic importance and vaccine development. DRUGS OF TODAY. 2009;45(suppl. B):147–50.
IEEE
[1]
K. Verminnen and D. Vanrompay, “Chlamydophila psittaci infections in turkeys : overview of economic and zoonotic importance and vaccine development,” DRUGS OF TODAY, vol. 45, no. suppl. B, pp. 147–150, 2009.
@article{806803,
  abstract     = {{We provide evidence on the multifactorial infectious etiology of respiratory disease in turkeys, Although Chlamydophila psittaci is difficult to diagnose, this entity should not be neglected in veterinary diagnostic laboratories. The present results suggest a pathogenic interplay between chlamydophila, avian metapneumovirus and Ornithobacterium rhinotracheale. Additionally, we demonstrate zoonotic transmission from turkeys to humans. Psittacosis due to contact with poultry probably occurs more often than is thought and the infection con be asymptomatic or symptomatic. There is no commercial C. psittaci vaccine available and currently the best option is an experimental major outer membrane protein-based DNA vaccine.}},
  author       = {{Verminnen, Kristel and Vanrompay, Daisy}},
  issn         = {{1699-3993}},
  journal      = {{DRUGS OF TODAY}},
  keywords     = {{CHALLENGE,PROTECTION,DNA VACCINATION,CHLAMYDIA-PSITTACI,OUTER-MEMBRANE PROTEIN}},
  language     = {{eng}},
  number       = {{suppl. B}},
  pages        = {{147--150}},
  title        = {{Chlamydophila psittaci infections in turkeys : overview of economic and zoonotic importance and vaccine development}},
  volume       = {{45}},
  year         = {{2009}},
}

Web of Science
Times cited: